Observation of a Transient Reaction Intermediate Illuminates the Mechanochemical Cycle of the AAA-ATPase p97.
Simon RydzekMikhail SheinPavlo BielytskyiAnne Kathrin SchützPublished in: Journal of the American Chemical Society (2020)
The human ATPase p97, also known as valosin containing protein or Cdc48, is a highly abundant AAA+ engine that fuels diverse energy-consuming processes in the human cell. p97 represents a potential target for cancer therapy and its malfunction causes a degenerative disease. Here, we monitor the enzymatic activity of p97 in real time via an NMR-based approach that allows us to follow the steps that couple ATP turnover to mechanical work. Our data identify a transient reaction intermediate, the elusive ADP.Pi nucleotide state, which has been postulated for many ATPases but has so far escaped direct detection. In p97, this species is crucial for the regulation of adenosine triphosphate turnover in the first nucleotide-binding domain. We further demonstrate how the enzymatic cycle is detuned by disease-associated gain-of-function mutations. The high-resolution insight obtained into conformational transitions in both protein and nucleotide bridges the gap between static enzyme structures and the dynamics of substrate conversion. Our approach relies on the close integration of solution- and solid-state NMR methods and is generally applicable to shed light on the mechanochemical operating modes of large molecular engines.
Keyphrases
- solid state
- high resolution
- endothelial cells
- cancer therapy
- pluripotent stem cells
- magnetic resonance
- induced pluripotent stem cells
- hydrogen peroxide
- single cell
- drug delivery
- single molecule
- cerebral ischemia
- protein protein
- bone mineral density
- electronic health record
- molecular dynamics
- cell therapy
- transcription factor
- blood brain barrier
- artificial intelligence
- risk assessment
- postmenopausal women
- dna binding